Skip to main content
. 2020 Jul 10;19:103. doi: 10.1186/s12904-020-00610-4

Table 2.

Common treatment-related adverse events (> 1% of patients) of grade ≥ 3 classified by System Organ Class and Preferred Term, (n = 113)

No. (%)
General disorders and alterations related to the administration site
 Asthenia 6 (5.3)
Hematological disorders
 Neutropenia 21 (18.6)
 Febrile neutropenia 5 (4.4)
 Thrombocytopenia 5 (4.4)
 Anemia 2 (1.8)
 Hemato-toxicity 2 (1.8)
Gastrointestinal disorders
 Diarrhea 3 (2.7)
Nervous system disorders
 Neurotoxicity 2 (1.8)